Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Lloyd

Showing results (611-620 of 624) with videos related to

Pageof 63
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 16, 2023
Somatostatin Receptor Type 2 and Thyroid-Stimulating Hormone Receptor Expression in Oncocytic Thyroid Neoplasms: Implications for Prognosis and TreatmentAndrea Gillis, Rui Zheng-Pywell, Chandler McLeod, et al.
Thyroid : Official Journal of the American Thyroid Association|December 18, 2010
Enhanced survival in locoregionally confined anaplastic thyroid carcinoma: a single-institution experience using aggressive multimodal therapyRobert L Foote, Julian R Molina, Jan L Kasperbauer, et al.
Genes, Chromosomes & Cancer|July 28, 2011
High-resolution genomic mapping reveals consistent amplification of the fibroblast growth factor receptor substrate 2 gene in well-differentiated and dedifferentiated liposarcomaXiaoke Wang, Yan W Asmann, Michele R Erickson-Johnson, et al.
Human Pathology|May 15, 2020
Data set for the reporting of pheochromocytoma and paraganglioma: explanations and recommendations of the guidelines from the International Collaboration on Cancer ReportingLester D R Thompson, Anthony J Gill, Sylvia L Asa, et al.
Genomics|November 24, 1999
Characterization of the human and mouse unconventional myosin XV genes responsible for hereditary deafness DFNB3 and shaker 2Y Liang, A Wang, I A Belyantseva, et al.
The American Journal of Surgical Pathology|September 17, 2004
Observer variation in the diagnosis of follicular variant of papillary thyroid carcinomaRicardo V Lloyd, Lori A Erickson, Mary B Casey, et al.
Surgery|November 2, 2023
Thyroid-stimulating hormone receptor (TSHR) as a target for imaging differentiated thyroid cancerGrayson R Gimblet, Jason Whitt, Hailey A Houson, et al.
Thyroid : Official Journal of the American Thyroid Association|October 13, 2017
Pathologic Reporting of Tall-Cell Variant of Papillary Thyroid Cancer: Have We Reached a Consensus?Juan C Hernandez-Prera, Rosalie A Machado, Sylvia L Asa, et al.
Cancer Research|December 17, 2008
Racial disparity in breast cancer and functional germ line mutation in galectin-3 (rs4644): a pilot studyVitaly Balan, Pratima Nangia-Makker, Ann G Schwartz, et al.
The American Journal of Surgical Pathology|February 2, 2010
Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data setDavid S Klimstra, Irvin R Modlin, N Volkan Adsay, et al.
Pageof 63

Showing results (611-620 of 624) with videos related to

Sort By:
Pageof 63
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 16, 2023
Somatostatin Receptor Type 2 and Thyroid-Stimulating Hormone Receptor Expression in Oncocytic Thyroid Neoplasms: Implications for Prognosis and TreatmentAndrea Gillis, Rui Zheng-Pywell, Chandler McLeod, et al.
Thyroid : Official Journal of the American Thyroid Association|December 18, 2010
Enhanced survival in locoregionally confined anaplastic thyroid carcinoma: a single-institution experience using aggressive multimodal therapyRobert L Foote, Julian R Molina, Jan L Kasperbauer, et al.
Genes, Chromosomes & Cancer|July 28, 2011
High-resolution genomic mapping reveals consistent amplification of the fibroblast growth factor receptor substrate 2 gene in well-differentiated and dedifferentiated liposarcomaXiaoke Wang, Yan W Asmann, Michele R Erickson-Johnson, et al.
Human Pathology|May 15, 2020
Data set for the reporting of pheochromocytoma and paraganglioma: explanations and recommendations of the guidelines from the International Collaboration on Cancer ReportingLester D R Thompson, Anthony J Gill, Sylvia L Asa, et al.
Genomics|November 24, 1999
Characterization of the human and mouse unconventional myosin XV genes responsible for hereditary deafness DFNB3 and shaker 2Y Liang, A Wang, I A Belyantseva, et al.
The American Journal of Surgical Pathology|September 17, 2004
Observer variation in the diagnosis of follicular variant of papillary thyroid carcinomaRicardo V Lloyd, Lori A Erickson, Mary B Casey, et al.
Surgery|November 2, 2023
Thyroid-stimulating hormone receptor (TSHR) as a target for imaging differentiated thyroid cancerGrayson R Gimblet, Jason Whitt, Hailey A Houson, et al.
Thyroid : Official Journal of the American Thyroid Association|October 13, 2017
Pathologic Reporting of Tall-Cell Variant of Papillary Thyroid Cancer: Have We Reached a Consensus?Juan C Hernandez-Prera, Rosalie A Machado, Sylvia L Asa, et al.
Cancer Research|December 17, 2008
Racial disparity in breast cancer and functional germ line mutation in galectin-3 (rs4644): a pilot studyVitaly Balan, Pratima Nangia-Makker, Ann G Schwartz, et al.
The American Journal of Surgical Pathology|February 2, 2010
Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data setDavid S Klimstra, Irvin R Modlin, N Volkan Adsay, et al.
Pageof 63